Flemming Steen Jensen
CIK: 0001965612
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ASND
Ascendis Pharma A/S
Officer
Discretionary Trading P&L
Holdings
About JENSEN FLEMMING STEEN
JENSEN FLEMMING STEEN (SEC CIK 0001965612) files insider reports with the SEC as Officer of Ascendis Pharma A/S (ASND).
Signal8 holds 2 ownership filings by JENSEN FLEMMING STEEN (1 Form 3, 1 Form 4), filed between Mar 18, 2026 and May 12, 2026. Those filings report 1 transaction, the latest on May 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on JENSEN FLEMMING STEEN's filings is in HELLERUP.
Recent filings by JENSEN FLEMMING STEEN
- May 11, 2026: Open-market sale of ASND shares (Form 4, code S).
Other insiders filing for Ascendis Pharma A/S (ASND)
- BIENAIME JEAN JACQUES, Director
- Bodenhoff Mads, SVP & PAO
- HOLTUG LARS, Director
- SMITH SCOTT THOMAS, EVP & Chief Financial Officer
- Fairey William, Director
- IMANI SIHAM, Director